Dongye Li Selected Research

Sarcoplasmic Reticulum Calcium-Transporting ATPases

1/2021	SERCA2a ameliorates cardiomyocyte T-tubule remodeling via the calpain/JPH2 pathway to improve cardiac function in myocardial ischemia/reperfusion mice.
1/2018	New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides.
1/2015	Luteolin Exerts Cardioprotective Effects through Improving Sarcoplasmic Reticulum Ca(2+)-ATPase Activity in Rats during Ischemia/Reperfusion In Vivo.
1/2013	ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dongye Li Research Topics

Disease

15	Ischemia 01/2022 - 01/2011
11	Reperfusion Injury 01/2022 - 10/2011
11	Myocardial Infarction 01/2022 - 06/2013
10	Heart Failure 06/2021 - 01/2012
8	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2016
7	Atherosclerosis 01/2020 - 05/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2012
5	Pathologic Constriction (Stenosis) 05/2021 - 01/2018
5	Hypoxia (Hypoxemia) 01/2019 - 04/2014
4	Inflammation (Inflammations) 01/2022 - 01/2014
3	Hemorrhage 11/2020 - 01/2020
3	Infarction (Infarctions) 01/2016 - 01/2011
2	Hypertension (High Blood Pressure) 01/2022 - 01/2022
2	Takotsubo Cardiomyopathy 12/2021 - 01/2021
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2015
2	Rupture 01/2020 - 01/2015
2	Neoplasms (Cancer) 03/2019 - 01/2017
2	Left Ventricular Dysfunction 01/2019 - 06/2013
2	Heart Diseases (Heart Disease) 10/2018 - 01/2018
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2015
2	Fibrosis (Cirrhosis) 01/2015 - 01/2012
2	Necrosis 11/2011 - 10/2011
1	Infections 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Non-ST Elevated Myocardial Infarction 01/2022
1	COVID-19 10/2021
1	Carotid Artery Diseases 05/2021
1	Heart Injuries 01/2021
1	Acute Coronary Syndrome 11/2020
1	Stroke (Strokes) 12/2019
1	Hypertrophy 01/2019
1	Carotid Stenosis (Carotid Artery Stenosis) 07/2018
1	Vascular Diseases (Vascular Disease) 04/2017
1	Dyspnea (Shortness of Breath) 03/2016
1	Insulin Resistance 01/2016

Drug/Important Bio-Agent (IBA)

16	LuteolinIBA 01/2022 - 01/2011
7	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 01/2011
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 04/2014
4	Estrogens (Estrogen)FDA Link 01/2022 - 01/2012
4	LipidsIBA 01/2022 - 03/2019
4	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 01/2021 - 01/2013
4	salvianolic acid AIBA 03/2019 - 11/2011
3	Neprilysin (Neutral Endopeptidase)IBA 06/2021 - 01/2019
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 06/2021 - 01/2019
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2012
3	FlavonoidsIBA 01/2017 - 01/2013
3	Dobutamine FDA LinkGeneric 11/2016 - 06/2013
2	Troponin IIBA 01/2022 - 01/2020
2	CalciumIBA 01/2022 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2019
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 07/2018
2	Phenobarbital (Luminal)FDA Link 12/2018 - 01/2018
2	LipopolysaccharidesIBA 04/2017 - 01/2014
2	Adenosine Triphosphatases (ATPase)IBA 01/2017 - 01/2017
2	pyrazolanthroneIBA 01/2016 - 01/2013
2	Caspase 3 (Caspase-3)IBA 01/2016 - 11/2011
2	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2014 - 01/2013
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	AngiotensinsIBA 10/2021
1	ReninIBA 10/2021
1	AldosteroneIBA 10/2021
1	CalpainIBA 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	TicagrelorIBA 11/2020
1	Biological ProductsIBA 11/2020
1	Clopidogrel (Plavix)FDA Link 11/2020
1	ChromatinIBA 01/2020
1	HomocysteineIBA 12/2019
1	Enalapril FDA LinkGeneric 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Peptide Elongation Factor 2 (EF-2)IBA 01/2019
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Therapeutic UsesIBA 01/2018
1	Natriuretic PeptidesIBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2017
1	Atrial Natriuretic Factor (ANF)IBA 03/2016
1	JNK Mitogen-Activated Protein KinasesIBA 01/2016
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2016
1	Sodium-Calcium ExchangerIBA 01/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016
1	ischemia-modified albuminIBA 08/2015
1	Atorvastatin (Lipitor)FDA Link 01/2015

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2014
3	Percutaneous Coronary Intervention 03/2019 - 12/2012
2	Ligation 01/2022 - 01/2016
1	Ovariectomy (Oophorectomy) 01/2022
1	Ischemic Postconditioning 01/2022
1	Carotid Endarterectomy 05/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2019
1	Thrombolytic Therapy 03/2019
1	Cutaneous Administration 01/2018